Inside the Lab: Advances in I-O Biomarkers
Activity Description:
This podcast will help participants to understand advances in I-O biomarker testing, advantages and limitations of some key I-O biomarkers, and practical ways that pathologists and laboratory professionals can improve their I-O biomarker testing workflows to optimize patient care.
Course topics include:
Recent advances in immune-oncology (I-O) biomarker testing
Advantages and limitations of IO biomarkers
Addressing challenges related to IO biomarkers
Improving IO biomarker workflows
Best practices for collaboration with the multidisciplinary cancer care team
Target Audience
This podcast has been designed to meet the educational needs of pathologists and laboratory professionals.
Faculty/Authors
Kurt Schalper, MD, PhD Associate Professor of Pathology Director, Translational Immuno-oncology Laboratory Yale School of Medicine, New Haven, Connecticut
Janis Taube, M.D. Professor, Department of Dermatology Director, Division of Dermatopathology Johns Hopkins University School of Medicine, Baltimore, MD
CME/CMLE Credit: 0.75Estimated Completion Time: 0.75 hour Format: Online Educational Activity Physician Competencies: Patient Care, Medical Knowledge, Practice-Based Learning, and Improvement Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).
Credit Designation Statement
The ASCP designates this activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .75 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation To complete the activity and receive credit, the participant must attend the program. CME certificates will be provided on-line.
Commercial Support
This activity is supported by an independent educational grant from Bristol Myers Squibb.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Technical Considerations
Release Date: 11/7/2024 Review Date:Expiration Date: 11/7/2027
Discuss strategies and techniques for optimizing the examination of resection specimens following neoadjuvant immunotherapy
Explore ways to strengthen collaboration and communication between pathologists and oncologists regarding resected samples following neoadjuvant immunotherapy
Describe the current state and future directions of cancer immunotherapy biomarkers and their implications for pathology practice
Compare and contrast the advantages and limitations of different types of I-O biomarkers (eg, PD-L1, TMB, MSI)
Optimize laboratory protocols and workflows for I-O biomarker testing (eg, gross examination, tissue fixation, processing, storage, staining, scoring, reporting, interpretation, and use of liquid biopsy and next generation sequencing [NGS])
Explore ways to strengthen collaboration and communication between pathologists and oncologists as new data on I-O biomarkers emerges